Maruyama T - Search Results

1

Molecular analysis of the human autoantibody response to alpha-fodrin in Sjögren's syndrome reveals novel apoptosis-induced specificity.

Maruyama T, Saito I, Hayashi Y, Kompfner E, Fox RI, Burton DR, Ditzel HJ. Maruyama T, et al. Am J Pathol. 2004 Jul;165(1):53-61. doi: 10.1016/s0002-9440(10)63274-9. Am J Pathol. 2004. PMID: 15215161 Free PMC article.

2

Detection of antibodies against the four subtypes of ebola virus in sera from any species using a novel antibody-phage indicator assay.

Meissner F, Maruyama T, Frentsch M, Hessell AJ, Rodriguez LL, Geisbert TW, Jahrling PB, Burton DR, Parren PW. Meissner F, et al. Among authors: maruyama t. Virology. 2002 Sep 1;300(2):236-43. doi: 10.1006/viro.2002.1533. Virology. 2002. PMID: 12350354 Free article.

3

Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge.

Law M, Maruyama T, Lewis J, Giang E, Tarr AW, Stamataki Z, Gastaminza P, Chisari FV, Jones IM, Fox RI, Ball JK, McKeating JA, Kneteman NM, Burton DR. Law M, et al. Among authors: maruyama t. Nat Med. 2008 Jan;14(1):25-7. doi: 10.1038/nm1698. Epub 2007 Dec 6. Nat Med. 2008. PMID: 18064037

4

Recombinant human monoclonal antibodies to Ebola virus.

Maruyama T, Parren PW, Sanchez A, Rensink I, Rodriguez LL, Khan AS, Peters CJ, Burton DR. Maruyama T, et al. J Infect Dis. 1999 Feb;179 Suppl 1:S235-9. doi: 10.1086/514280. J Infect Dis. 1999. PMID: 9988189

5

Pre- and postexposure prophylaxis of Ebola virus infection in an animal model by passive transfer of a neutralizing human antibody.

Parren PW, Geisbert TW, Maruyama T, Jahrling PB, Burton DR. Parren PW, et al. Among authors: maruyama t. J Virol. 2002 Jun;76(12):6408-12. doi: 10.1128/jvi.76.12.6408-6412.2002. J Virol. 2002. PMID: 12021376 Free PMC article.

6

Ebola virus can be effectively neutralized by antibody produced in natural human infection.

Maruyama T, Rodriguez LL, Jahrling PB, Sanchez A, Khan AS, Nichol ST, Peters CJ, Parren PW, Burton DR. Maruyama T, et al. J Virol. 1999 Jul;73(7):6024-30. doi: 10.1128/JVI.73.7.6024-6030.1999. J Virol. 1999. PMID: 10364354 Free PMC article.

7

Antibody elicited against the gp41 N-heptad repeat (NHR) coiled-coil can neutralize HIV-1 with modest potency but non-neutralizing antibodies also bind to NHR mimetics.

Nelson JD, Kinkead H, Brunel FM, Leaman D, Jensen R, Louis JM, Maruyama T, Bewley CA, Bowdish K, Clore GM, Dawson PE, Frederickson S, Mage RG, Richman DD, Burton DR, Zwick MB. Nelson JD, et al. Among authors: maruyama t. Virology. 2008 Jul 20;377(1):170-83. doi: 10.1016/j.virol.2008.04.005. Epub 2008 May 21. Virology. 2008. PMID: 18499210 Free PMC article.

8

Complete replication of hepatitis C virus in cell culture.

Lindenbach BD, Evans MJ, Syder AJ, Wölk B, Tellinghuisen TL, Liu CC, Maruyama T, Hynes RO, Burton DR, McKeating JA, Rice CM. Lindenbach BD, et al. Among authors: maruyama t. Science. 2005 Jul 22;309(5734):623-6. doi: 10.1126/science.1114016. Epub 2005 Jun 9. Science. 2005. PMID: 15947137 Free article.

9

The first human epitope map of the alphaviral E1 and E2 proteins reveals a new E2 epitope with significant virus neutralizing activity.

Hunt AR, Frederickson S, Maruyama T, Roehrig JT, Blair CD. Hunt AR, et al. Among authors: maruyama t. PLoS Negl Trop Dis. 2010 Jul 13;4(7):e739. doi: 10.1371/journal.pntd.0000739. PLoS Negl Trop Dis. 2010. PMID: 20644615 Free PMC article.

10

Human antibodies from immunized donors are protective against anthrax toxin in vivo.

Wild MA, Xin H, Maruyama T, Nolan MJ, Calveley PM, Malone JD, Wallace MR, Bowdish KS. Wild MA, et al. Among authors: maruyama t. Nat Biotechnol. 2003 Nov;21(11):1305-6. doi: 10.1038/nbt891. Epub 2003 Oct 12. Nat Biotechnol. 2003. PMID: 14555959

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,483 results

Search Page